Analysis and Commentary 5/21/21 Analysis and Commentary 5/21/21 Messaging for Upcoming Senate Hill Days Read More Advocacy at a Glance 5/21/21 Advocacy at a Glance 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Analysis and Commentary 6/26/20 Analysis and Commentary 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More Advocacy at a Glance 3/27/20 Advocacy at a Glance 3/27/20 FDA Gains $80 Million in Third Pandemic Relief Bill Read More Advocacy at a Glance 3/20/20 Advocacy at a Glance 3/20/20 Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides Read More Advocacy at a Glance 3/13/20 Advocacy at a Glance 3/13/20 The Alliance’s March 18 Hill Day Is Still On; New Format to Deliver FDA Funding Message Safely Read More Analysis and Commentary 2/27/20 Analysis and Commentary 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More Advocacy at a Glance 2/21/20 Advocacy at a Glance 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More Advocacy at a Glance 2/7/20 Advocacy at a Glance 2/7/20 Upcoming Alliance Events Read More Advocacy at a Glance 1/25/20 Advocacy at a Glance 1/25/20 Notes from the Alliance Meeting with CBER Director, Dr. Peter Marks Read More Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More Analysis and Commentary 12/16/19 Analysis and Commentary 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More Analysis and Commentary 8/2/19 Analysis and Commentary 8/2/19 From Budget Deal to FY 20 Appropriations: Reasons for Optimism? Read More Analysis and Commentary 7/12/19 Analysis and Commentary 7/12/19 Education and Advocacy for FDA Is a Year-Round Priority Read More Advocacy at a Glance 4/12/19 Advocacy at a Glance 4/12/19 Hearings on FDA’s Budget are Completed. What Next? Read More Advocacy at a Glance 3/22/19 Advocacy at a Glance 3/22/19 Alliance Hill Day Tops 60 Meetings Read More Advocacy at a Glance 3/16/19 Advocacy at a Glance 3/16/19 Hill Day Coming at the Perfect Time. Now We Need You to Participate Read More Advocacy at a Glance 3/8/19 Advocacy at a Glance 3/8/19 President’s FY 20 Budget Request (Skinny Version) to Be Released Week of March 11 Read More Analysis and Commentary 2/22/19 Analysis and Commentary 2/22/19 Four More Qs and Four More As Read More Older Posts
Analysis and Commentary 5/21/21 Analysis and Commentary 5/21/21 Messaging for Upcoming Senate Hill Days Read More
Advocacy at a Glance 5/21/21 Advocacy at a Glance 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Analysis and Commentary 6/26/20 Analysis and Commentary 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More
Advocacy at a Glance 3/27/20 Advocacy at a Glance 3/27/20 FDA Gains $80 Million in Third Pandemic Relief Bill Read More
Advocacy at a Glance 3/20/20 Advocacy at a Glance 3/20/20 Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides Read More
Advocacy at a Glance 3/13/20 Advocacy at a Glance 3/13/20 The Alliance’s March 18 Hill Day Is Still On; New Format to Deliver FDA Funding Message Safely Read More
Analysis and Commentary 2/27/20 Analysis and Commentary 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More
Advocacy at a Glance 2/21/20 Advocacy at a Glance 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More
Advocacy at a Glance 1/25/20 Advocacy at a Glance 1/25/20 Notes from the Alliance Meeting with CBER Director, Dr. Peter Marks Read More
Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More
Analysis and Commentary 12/16/19 Analysis and Commentary 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More
Analysis and Commentary 8/2/19 Analysis and Commentary 8/2/19 From Budget Deal to FY 20 Appropriations: Reasons for Optimism? Read More
Analysis and Commentary 7/12/19 Analysis and Commentary 7/12/19 Education and Advocacy for FDA Is a Year-Round Priority Read More
Advocacy at a Glance 4/12/19 Advocacy at a Glance 4/12/19 Hearings on FDA’s Budget are Completed. What Next? Read More
Advocacy at a Glance 3/22/19 Advocacy at a Glance 3/22/19 Alliance Hill Day Tops 60 Meetings Read More
Advocacy at a Glance 3/16/19 Advocacy at a Glance 3/16/19 Hill Day Coming at the Perfect Time. Now We Need You to Participate Read More
Advocacy at a Glance 3/8/19 Advocacy at a Glance 3/8/19 President’s FY 20 Budget Request (Skinny Version) to Be Released Week of March 11 Read More
Analysis and Commentary 2/22/19 Analysis and Commentary 2/22/19 Four More Qs and Four More As Read More
